We used a human platelet oj-adrenergic receptor probe to study the tissue distribution and messenger RNA (mRNA) forms of the rat Oj-adrenergic receptor. Under stringent conditions of hybridization and washing, we detected an mRNA species of 3.8 kb. The abundance of this form follows the order spleen, kidney, brain stem and cortex, and skeletal muscle and lung and is consistent with the reported abundance and tissue distribution of the <*t receptor activity. A 3.0 kb mRNA form was also detected in cerebral cortex and brain stem and a 4.1 kb mRNA form was observed in kidney under less stringent hybridization conditions. The tissue distribution of the 3.0 kb form is different from that of or,-and /J-adrenergic receptors and the D 2 dopaminergic receptor. The mRNA analysis combined with Southern blot analysis of rat and human genomic DNA indicate that: 1) in addition to a 3.8 kb rat a^-adrenergic receptor transcript, there are other mRNA forms in the rat that do not correspond to previously described adrenergic receptor mRNA species and 2) more than one o^-adrenergic receptor gene in the rat is expressed in a tissue-specific manner. The recent cloning of genes or complementary DNA (cDNA) for several of these receptors has revealed extensive sequence homology and conservation of common structural features. All these receptors have a similar topographic organization and contain seven transmembrane domains with conserved amino acid sequences. 2 -3 This sequence conservation has allowed the use of heterologous probes for messenger RNA (mRNA) detection as well as the isolation of several members of the adrenergic receptor gene family from different species.
T he a 2 -adrenergic receptor is a member of the family of integral membrane receptors involved in the G protein-mediated signal transduction. 1 -4 This family includes the a,-, a 2 -, ft-, and ft-adrenergic receptors, 2 -3 several subtypes of muscarinic cholinergic receptors, 5 the dopamine receptor, 6 the substance K receptor, 7 the serotonin receptor gene, 89 and the gene of light receptor rhodopsin. 10 The recent cloning of genes or complementary DNA (cDNA) for several of these receptors has revealed extensive sequence homology and conservation of common structural features. All these receptors have a similar topographic organization and contain seven transmembrane domains with conserved amino acid sequences.
The cloning and biochemical characterization of a r adrenergic receptors has provided insight into the adrenergic receptor heterogeneity. 12 - 14 Earlier ligand binding studies of a 2 -adrenergic receptors from various tissues and species have suggested the presence of two subtypes of a 2 receptors: The a^ subtype is represented by the platelet a 2 -adrenergic receptor, has a low affinity for prazosin, and migrates in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as a broad band with an apparent molecular weight of 64 kd. 14 - 17 The aŝ ubtype is represented by the neonatal rat lung aradrenergic receptor, has a high affinity for prazosin, and an apparent molecular weight of 44 kd.
-

16
- 18 The biochemical characterization of the a 2 receptor has suggested that the differences in their ligand binding properties cannot be accounted for by differences in glycosylation and therefore should be attributed to differences in their primary structures. 14 Molecular cloning of human adrenergic receptor gene has shown the existence of several (at least two) distinct adrenergic receptor genes.
"
14 Expression of a human platelet gene and a human kidney cDNA showed that the former gene encodes for a receptor with oi2A and the latter for a receptor with a w subtype properties.
12
- 13 The two genes display 75% amino acid sequence homology over their transmembrane domain but diverge at their amino terminus (14%).
In the present study, using the human platelet a 2 -adrenergic receptor gene DNA as a probe, we studied the transcription of the rat a r adrenergic receptor. We found that there are several distinct aradrenergic receptor mRNA species in rat, which appear to be expressed from different genes in a tissue-specific manner. 
Methods
Materials
RNA Isolation and Blotting
Male Wistar rats (Charles River Laboratories, Kingston, N.Y.), weighing 200-250 g and receiving standard diet and tap water, were killed by decapitation, and the various organs were removed within 5 minutes, washed in ice cold phosphate buffer saline (PBS) to remove excess blood, frozen in liquid nitrogen, and stored at -80° C for further use. Before it was frozen, the brain was dissected into two parts: cerebral cortex and the brain stem minus the cerebellum. For some experiments the brain was dissected in segments: cortex, diencephalon and mesencephalon, pons-medulla, and cerebellum. The HT29 human colon adenocarcinoma cell line (passage 128) was maintained in an atmosphere of 95% air and 5% CO 2 at 37° C in l x McCoy's 5A medium supplemented with 10% fetal bovine serum, penicillin 100 IU/ml, and streptomycin 100 mcg/ml. The medium was changed every 2-3 days, and confluent monolayers were split at the ratio 1 : 4. Before RNA isolation, confluent monolayers were washed three times with ice cold PBS, scraped off with a rubber policeman, and pelleted by centrifugation. Total cellular RNA was extracted by a modified method of Chirgwin et al 19 and other researchers 20 -21 : frozen organs were mixed with approximately five volumes guanidine isothiocyanate buffer (4 M guanidine isothiocyanate, 50 mM sodium acetate, pH 6, 0.15 M 2-mercaptoethanol) and homogenized for 50 seconds using a Pofytron. To the homogenate sodium lauryl sarkosine was added to a 0.5% final concentration, and the homogenate was forced twice through a 22 gauge needle. Six milliliters of the homogenate were layered on a 6 ml cushion of 5.7 M CsQ, 50 mM sodium acetate, pH 6, and 20 mM EDTA in a quick-seal tube (model 342413, Beckman Instruments, Inc., Fullerton, Calif.) and centrifuged at 35,000 rpm for 16 hours at 20° C in a Type 70.1 Ti rotor. The pellet was washed thoroughly with 70% ethanol and resuspended in diethylpyrocarbonate-treated sterile water. RNA from the HT29 cell line was extracted as above except that the original cell pellet was not homogenized by Polytron but was dissolved in guanidine isothiocyanate buffer by vigorous vortexing.
Polyadenylated RNA was selected by passing twice over an oligo(dT)-cellulose column. Samples of total or poly (A) + RNA were electrophoresed on 1% agarose gel prepared in 20 mM 3-(7V-morpholino)propanesulfonic acid (MOPS) pH 7, 5 mM sodium acetate, 1 mM EDTA, 3% formaldehyde (unless otherwise cited), and ethidium bromide 0.5 ^g/ml. After electrophoresis, the RNA was transferred to membranes by overnight blotting. Filters were processed as described in the legend of Figures 1 and 2 .
DNA Blotting
For Southern blotting, high molecular weight DNA was isolated from rat liver and human placenta according to standard methods 21 and was digested with restriction enzymes for at least 5 hours at 37° C using 5 units enzyme per microgram DNA. Restriction enzyme digests were electrophoresed, blotted, and hybridized as described in the legend of Figure 4 .
Probes
The human platelet a 2 -adrenergic receptor probe was derived from a 1.6 kb Ncol/HindlH fragment of the pUC18-human a 2 -BamHl genomic subclone. The plasmid DNA was digested with Ncol and Hindlll, and the resulting fragments were resolved on a 1% agarose gel. The 1.6 kb fragment was electroeluted, purified over a DE-52 cellulose column, and labeled by the random primed DNA labeling method using a kit from Boehringer Mannheim Biochemicals.
Similarly, the rat D 2 dopamine receptor probe was derived from a 500 bp XbaU-EcoRl fragment of the pD2 Sacl-Bgllll subclone, also labeled by the random primed DNA labeling method. 22 
Results
Expression of a T Adrenergic Receptor-Related Transcripts in Different Rat Tissues
Northern blot analysis of RNA isolated from rat kidney and skeletal muscle and hybridization with the human a 2 -adrenergic receptor probe showed under stringent washing conditions (O.lxSSC [0.15 M sodium chloride; 0.015 M sodium citrate], 0.1% SDS at 55° C) the presence of a 3.8 kb mRNA band. A second hybridizing band 4.1 kb was detected under less stringent washing conditions (0.5xSSC, 0.1% SDS at 55° C) (Figure 1) .
The distribution of a 2 -related mRNA species in different rat tissues is shown in Figure 2A -2C. At least three different and distinct a 2 mRNA species 4.1 kb, 3.8 kb, and 3.0 kb long can be observed in the various rat tissues. The 3.8 kb mRNA is the major species and its relative abundance in the rat tissues follows the order spleen>kidney>brain stem and cerebral cortex>skeletal muscle and lung. This distribution is consistent with the reported tissue distribution of the a 2 receptor ligand binding activity. 16 Under less stringent washing conditions (0.5 x SSC, 0.1% SDS at 55° C) brain (stem and cortex) and kidney show the presence of a 3.0 kb and 4.1 kb mRNA species respectively. The detection of these mRNA species was found in our experiments to be remarkably diminished or completely abolished under the high stringency conditions depending on the specific activity of the probes used. In subsequent experiments, when the carboxyl terminal portion of the human a 2 receptor gene was used as a probe, an additional 4.6 kb mRNA species was also detected in kidney and spleen (Figure 3) .
In Figure 2 , a high molecular weight diffuse smear appears in the spleen lane. This was not found in subsequent experiments, and it probably represents impurities in that particular RNA sample.
In the liver, the 3.8 kb form is absent. However, two weakly hybridizing bands of 4.1 kb and 4.6 kb are present.
Blotting analysis of rat mRNA along with mRNA from human and monkey tissues 23 allowed comparison of the a 2 -adrenergic receptor transcripts between these species ( Figure 2C ). Under stringent washing conditions (O.lxSSC, 0.1% SDS at 55°C) a single mRNA species 3.8 kb was detected in rat kidney, monkey, and human spleen, and the HT29, a human adenocarcinoma cell line that expresses functional a 2 -adrenergic receptor. 24 
Heterogeneity of Rat a 2 -Adrenergic Receptor Messenger RNA Species
Use of different segments of human a 2 receptor gene as hybridization probes suggested that the rat « 2 -adrenergic receptor transcripts were heterogeneous ( Figure 3 ). Thus, a 712 bp Smal/Smal fragment, designated probe A, which encodes the first five transmembrane domains, hybridized readily to all the mRNA species that have been detected using the entire a 2 receptor probe. In contrast, a 497 bp Smal/Smal fragment, designated probe B, which encodes the sixth and seventh membrane-spanning regions, the carboxyl terminus and portion of the 3' noncoding region hybridized weakly to the 3.8 kb mRNA, but strongly to the 4.1 kb mRNA form of kidney. An additional band, 4.6 kb, was detected in kidney and spleen as well. The 3.0 kb band was not detectable with this probe. Finally, a 200 bp Ncoll Ncol region immediately upstream to the coding region hybridized to the 3.8 kb mRNA and to the 4.6 kb mRNA form of kidney, but not to the 3.0 kb form of brain or the 4.1 kb form in kidney.
Digestion of rat and human genomic DNAs with Mndlll or BamHl plus Hindlll and subsequent DNA blotting analysis showed that the former digestion produced a hybridization band of 4.0 and the latter a band 3.0 kb for both the human and the rat DNAs ( Figure 4B ). Additional weak hybridization bands were obtained for both the human and rat DNAs under less stringent washing conditions (Figure 4A) . These additional weak bands may represent other genes that are homologous to the a 2 -adrenergic receptor gene. Similar bands in DNA from the human genome have been shown previously to represent a 2 -related genes. 12 To test the possibility that the 3.0 kb mRNA form might represent a D 2 script, 6 a membrane strip containing rat brain mRNA was sequentially hybridized to the a 2 -specific probe and then to the D 2 dopaminergic receptor cDNA probe. As explained in the legend of Figure 5 , the former hybridization produces two bands of approximately 3.8 kb and 3.0 kb, respectively, and the latter one band of approximately 3.0 kb ( Figure 5A ).
Superimposition of the two autoradiograms showed that the 3.0 kb a 2 mRNA species is slightly smaller than the D 2 dopaminergic receptor mRNA. Furthermore, we have found that the distribution of D 2 receptor mRNA in various regions of brain is different from that of the 3.0 kb a 2 -like mRNA species. As can be observed in Figure 5C a r adrenergic receptor probe detects mRNA species in cerebral cortex, diencephalon-mesencephalon, pons-medulla, and cerebellum. In contrast, the D 2 dopaminergic receptor mRNA is almost undetectable in cerebellum ( Figure 5B ).
Discussion
The findings of Figures 2 and 3 are consistent with the hypothesis that the 3.8 kb mRNA species represents the rat equivalent of the human platelet ct 2 -adrenergic receptor transcript and that the 4.1 kb and 4.6 kb transcripts present in kidney and the 3.0 kb mRNA detected in brain are homologous to certain regions of the human a 2 receptor gene. This interpretation would imply that the human platelet a 2 -adrenergic receptor mRNA and its rat 3.8 kb counterpart have greater homology in their amino as compared with their carboxyl terminal domains. In contrast, the 4.1 kb and 4.6 kb transcripts present in kidney have greater homology to the carboxyl than the amino terminal portion of the human platelet « 2 -adrenergic receptor gene. The 4.6 kb, 4.1 kb, and 3.0 kb mRNA species may in principle be products of different but homologous genes, or they may result from different mRNA processing of an original transcript, or a combination of both. Assuming that the entire « 2 -adrenergic receptor gene (including the sequences encoding for the 5' and 3' untranslated region) is intronless, 12 -25 the molecular heterogeneity of the rat a 2 -adrenergic receptor mRNA species shown in the present study would indicate that the different mRNA species are most likely products of different genes.
We have considered the possibility that the 3.0 kb mRNA detected in rat brain may represent a transcript of the /3 r or a,-adrenergic receptor or the D 2 dopaminergic receptor gene. It is known that the human a r and /3 r adrenergic receptor and the rat D 2 dopamine receptor genes have 44%, 45%, and 48% sequence homology, respectively, with that of the human platelet a 2 membrane regions. However, the tissue distribution of the j8i mRNA in rat tissues is different from that of the 3.0 kb mRNA form observed in the present study. The former is approximately 2.5 kb long and is present in heart, lung, and brain, 11 whereas the latter is present only in brain (Figure 2A ). In addition, recent analysis of a^adrenergic receptor mRNA in dog tissues shows the presence of an approximately 3.0 kb mRNA species predominantly in heart and to a lesser extent in brain and lung. 26 Furthermore, our comparative analysis of the transcription of the D 2 dopaminergic receptor gene has distinguished the 3.0 kb mRNA species detected by the a 2 -specific probe from the 3.1 kb D 2 dopaminergic receptor mRNA.
Based on the high stringency conditions used in our experiments (O.lxSSC, 0.1% SDS, 55° C) and the rest of the circumstantial evidence presented in this study, we believe that the mRNA species detected in the rat tissues by the human platelet a 2 -adrenergic receptor probe are a 2 -specific. It should be emphasized, however, that the a 2 -related mRNA species observed in rat tissues could possibly encode for proteins, which have structural homology to but are functionally different from the a 2 -adrenergic receptor. A similar relation has been found with the serotonin receptor gene, 89 which despite its structural similarity with all known adrenergic receptors, encodes for a protein recognizing serotonin rather than catecholamines. 89 Although the identity of the mRNAs detected in the present study will be ultimately resolved by the cloning and sequencing of cDNA copies corresponding to these mRNAs and subsequent expression in eukaryotic cells, we believe that the present data showing a tissue-specific expression of a 2 -related mRNAs in the rat tissues will facilitate studies of a 2 -adrenergic receptor gene expression in hypertensive models.
